How to test for Prader-Willi syndrome?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 10, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Diagnostic Testing for Prader-Willi Syndrome

DNA methylation analysis should be the first-line diagnostic test for Prader-Willi syndrome as it can detect all three major genetic mechanisms causing PWS (deletion, uniparental disomy, and imprinting defects). 1, 2

Primary Diagnostic Approach

Step 1: Methylation Analysis

  • Perform DNA methylation analysis using Southern hybridization with methylation-sensitive SNRPN or PW71B probes
  • Results interpretation:
    • If only maternal methylation pattern is present → PWS is confirmed
    • If biparental methylation pattern is present → PWS is ruled out
    • If only paternal methylation pattern is present → Consider Angelman syndrome instead

Step 2: Determine Genetic Mechanism (if methylation is abnormal)

After confirming PWS by methylation analysis, determine the specific genetic mechanism:

  1. FISH Analysis:

    • Use SNRPN or other probes from 15q11-13 region along with centromeric probe
    • If deletion is detected → PWS due to deletion (accounts for ~70% of cases) 1, 3
    • If no deletion is detected → Proceed to UPD testing
  2. UPD Testing:

    • Perform PCR using microsatellite markers from 15q11-13
    • If maternal UPD is present → PWS due to uniparental disomy (accounts for ~25% of cases) 1, 2
    • If biparental inheritance with abnormal methylation → Likely imprinting mutation (accounts for <5% of cases) 1, 3

Alternative Diagnostic Approach

If methylation analysis is not available, an alternative approach is:

  1. High-resolution chromosome analysis (550-band level) and FISH using SNRPN probe 1, 4
  2. If deletion is detected → Confirm PWS with methylation analysis
  3. If no deletion is detected → Perform methylation analysis to detect UPD or imprinting defects

Clinical Considerations

  • Methylation analysis is the most efficient primary screening test as it can detect all three major genetic mechanisms causing PWS 1, 2
  • FISH analysis alone will miss approximately 30% of PWS cases (those due to UPD or imprinting defects) 1, 5
  • Real-time PCR can be used to determine the size of chromosomal deletions in PWS patients 3

Genetic Counseling Implications

  • Deletion cases: Generally sporadic with low recurrence risk (~1%) 1
  • UPD cases: Generally sporadic with low recurrence risk (~1%) 1
  • Imprinting mutations: May have substantial recurrence risk (up to 50%) 1

Common Pitfalls to Avoid

  • Relying solely on FISH analysis will miss cases caused by UPD or imprinting defects 1, 5
  • Clinical diagnosis without genetic confirmation is insufficient due to overlapping features with other syndromes 1, 6
  • If clinical suspicion remains high despite normal test results, consider:
    • Consultation with a clinician experienced with PWS 1
    • Evaluation for other conditions with overlapping phenotypes (e.g., fragile X, Williams syndrome) 1
    • Referral to specialized research laboratories for further investigation 1

Prenatal Testing

Prenatal testing is possible in families with a previously affected child:

  • For deletion cases: FISH analysis on CVS or amniocentesis samples 1
  • For UPD cases: PCR and microsatellite analysis 1
  • For imprinting mutations: Testing for previously identified mutation 1

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Prader-Willi syndrome: clinical and molecular cytogenetic investigations.

Journal of the Formosan Medical Association = Taiwan yi zhi, 1996

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.